Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis

Am J Med. 2000 Jun 15;108(9):730-2. doi: 10.1016/s0002-9343(00)00406-x.

Authors

M A Hamidou¹, F B Sadr, T Lamy, F Raffi, J Y Grolleau, J H Barrier

Affiliation

¹ Department of Internal Medicine, Centre Hospitalier Universitaire de Nantes, France.

PMID: 10924650
DOI: 10.1016/s0002-9343(00)00406-x

No abstract available

MeSH terms

Aged
Antimetabolites, Antineoplastic / administration & dosage
Antimetabolites, Antineoplastic / therapeutic use*
Antirheumatic Agents / administration & dosage
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / complications*
Arthritis, Rheumatoid / drug therapy*
Female
Humans
Leukemia, Myeloid / complications*
Leukemia, Myeloid / drug therapy*
Leukocyte Count / drug effects
Lymphocyte Count / drug effects
Methotrexate / administration & dosage
Methotrexate / therapeutic use*
Middle Aged
Neutrophils / drug effects
Retrospective Studies
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Antirheumatic Agents
Methotrexate